99 related articles for article (PubMed ID: 11106258)
1. The importance of p53-independent apoptosis in the intestinal toxicity induced by raltitrexed (ZD1694, Tomudex): genetic differences between BALB/c and DBA/2 mice.
Pritchard DM; Bower L; Potten CS; Jackman AL; Hickman JA
Clin Cancer Res; 2000 Nov; 6(11):4389-95. PubMed ID: 11106258
[TBL] [Abstract][Full Text] [Related]
2. Balb/c mice as a preclinical model for raltitrexed-induced gastrointestinal toxicity.
Clarke SJ; Farrugia DC; Aherne GW; Pritchard DM; Benstead J; Jackman AL
Clin Cancer Res; 2000 Jan; 6(1):285-96. PubMed ID: 10656460
[TBL] [Abstract][Full Text] [Related]
3. The relationships between p53-dependent apoptosis, inhibition of proliferation, and 5-fluorouracil-induced histopathology in murine intestinal epithelia.
Pritchard DM; Potten CS; Hickman JA
Cancer Res; 1998 Dec; 58(23):5453-65. PubMed ID: 9850079
[TBL] [Abstract][Full Text] [Related]
4. Leucovorin rescue from raltitrexed (tomudex)-induced antiproliferative effects: in vitro cell line and in vivo mouse studies.
Farrugia DC; Aherne GW; Brunton L; Clarke SJ; Jackman AL
Clin Cancer Res; 2000 Sep; 6(9):3646-56. PubMed ID: 10999757
[TBL] [Abstract][Full Text] [Related]
5. Apoptosis in small intestinal epithelial from p53-null mice: evidence for a delayed, p53-independent G2/M-associated cell death after gamma-irradiation.
Merritt AJ; Allen TD; Potten CS; Hickman JA
Oncogene; 1997 Jun; 14(23):2759-66. PubMed ID: 9190891
[TBL] [Abstract][Full Text] [Related]
6. Differential post-translational modification of the tumour suppressor proteins Rb and p53 modulate the rates of radiation-induced apoptosis in vivo.
Wallace M; Coates PJ; Wright EG; Ball KL
Oncogene; 2001 Jun; 20(28):3597-608. PubMed ID: 11439323
[TBL] [Abstract][Full Text] [Related]
7. The role of p53 in spontaneous and radiation-induced apoptosis in the gastrointestinal tract of normal and p53-deficient mice.
Merritt AJ; Potten CS; Kemp CJ; Hickman JA; Balmain A; Lane DP; Hall PA
Cancer Res; 1994 Feb; 54(3):614-7. PubMed ID: 8306319
[TBL] [Abstract][Full Text] [Related]
8. Chemically-induced apoptosis: p21 and p53 as determinants of enterotoxin activity.
Pritchard DM; Jackman A; Potten CS; Hickman JA
Toxicol Lett; 1998 Dec; 102-103():19-27. PubMed ID: 10022227
[TBL] [Abstract][Full Text] [Related]
9. The impact of p53 status on cellular sensitivity to antifolate drugs.
Lu X; Errington J; Curtin NJ; Lunec J; Newell DR
Clin Cancer Res; 2001 Jul; 7(7):2114-23. PubMed ID: 11448931
[TBL] [Abstract][Full Text] [Related]
10. The roles of thymidylate synthase and p53 in regulating Fas-mediated apoptosis in response to antimetabolites.
Longley DB; Allen WL; McDermott U; Wilson TR; Latif T; Boyer J; Lynch M; Johnston PG
Clin Cancer Res; 2004 May; 10(10):3562-71. PubMed ID: 15161716
[TBL] [Abstract][Full Text] [Related]
11. Synergistic antitumour effect of raltitrexed and 5-fluorouracil plus folinic acid combination in human cancer cells.
Avallone A; Di Gennaro E; Bruzzese F; Laus G; Delrio P; Caraglia M; Pepe S; Comella P; Budillon A
Anticancer Drugs; 2007 Aug; 18(7):781-91. PubMed ID: 17581300
[TBL] [Abstract][Full Text] [Related]
12. Gene expression and apoptosis induction in p53-heterozygous irradiated mice.
di Masi A; Antoccia A; Dimauro I; Argentino-Storino A; Mosiello A; Mango R; Novelli G; Tanzarella C
Mutat Res; 2006 Feb; 594(1-2):49-62. PubMed ID: 16169021
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of Bax enhances antitumor activity of chemotherapeutic agents in human head and neck squamous cell carcinoma.
Guo B; Cao S; Tóth K; Azrak RG; Rustum YM
Clin Cancer Res; 2000 Feb; 6(2):718-24. PubMed ID: 10690558
[TBL] [Abstract][Full Text] [Related]
14. Apoptosis, cell cycle progression and gene expression in TP53-depleted HCT116 colon cancer cells in response to short-term 5-fluorouracil treatment.
Adamsen BL; Kravik KL; Clausen OP; De Angelis PM
Int J Oncol; 2007 Dec; 31(6):1491-500. PubMed ID: 17982676
[TBL] [Abstract][Full Text] [Related]
15. Molecular downstream events and induction of thymidylate synthase in mutant and wild-type p53 colon cancer cell lines after treatment with 5-fluorouracil and the thymidylate synthase inhibitor raltitrexed.
Peters GJ; van Triest B; Backus HH; Kuiper CM; van der Wilt CL; Pinedo HM
Eur J Cancer; 2000 May; 36(7):916-24. PubMed ID: 10785598
[TBL] [Abstract][Full Text] [Related]
16. p53 induction and apoptosis in response to radio- and chemotherapy in vivo is tumor-type-dependent.
Kemp CJ; Sun S; Gurley KE
Cancer Res; 2001 Jan; 61(1):327-32. PubMed ID: 11196181
[TBL] [Abstract][Full Text] [Related]
17. c-myc/p53 interaction determines sensitivity of human colon carcinoma cells to 5-fluorouracil in vitro and in vivo.
Arango D; Corner GA; Wadler S; Catalano PJ; Augenlicht LH
Cancer Res; 2001 Jun; 61(12):4910-5. PubMed ID: 11406570
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics studies and toxicity profile of raltitrexed used by intraperitoneal route in normothermia in a pig model.
Nguyen D; Emond C; Leclerc Y; Sherman I; Dube P
Med Sci Monit; 2003 Jan; 9(1):BR37-42. PubMed ID: 12552235
[TBL] [Abstract][Full Text] [Related]
19. The role of thymidylate synthase induction in modulating p53-regulated gene expression in response to 5-fluorouracil and antifolates.
Longley DB; Boyer J; Allen WL; Latif T; Ferguson PR; Maxwell PJ; McDermott U; Lynch M; Harkin DP; Johnston PG
Cancer Res; 2002 May; 62(9):2644-9. PubMed ID: 11980662
[TBL] [Abstract][Full Text] [Related]
20. Modulation of both endogenous folates and thymidine enhance the therapeutic efficacy of thymidylate synthase inhibitors.
van der Wilt CL; Backus HH; Smid K; Comijn L; Veerman G; Wouters D; Voorn DA; Priest DG; Bunni MA; Mitchell F; Jackman AL; Jansen G; Peters GJ
Cancer Res; 2001 May; 61(9):3675-81. PubMed ID: 11325838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
